-
Edmondson,S.D., Mastracchio,A., Mathvink,R.J., He,J., Harper,B., Park,Y.J., Beconi,M., Di Salvo,J., Eiermann,G.J., He,H., Leiting,B., Leone,J.F., Levorse,D.A., Lyons,K., Patel,R.A., Patel,S.B., Petrov,A., Scapin,G., Shang,J., Roy,R.S., Smith,A., Wu,J.K., Xu,S., Zhu,B., Thornberry,N.A. and Weber,A.E.
(2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1 ,2,4]triazolo[1,5-a]- pyridin-6-ylphenyl)butanamide: a selective alpha-amino amide dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
J Med Chem (2006) 49, 3614-3627. PubMed Europe PubMed DOI I
2006
